NCT03483636View on ClinicalTrials.gov

Study of Lemborexant-Alcohol Interaction in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 12, 2018

Primary Completion Date

September 12, 2018

Study Completion Date

September 12, 2018

Conditions
Healthy Subjects
Interventions
DRUG

Lemborexant

Film-coated oral tablet

DRUG

Alcohol

0.6 g/kg (female) or 0.7 g/kg (male) of 40% ethanol (volume per volume) vodka diluted in a low-calorie beverage (e.g., cranberry beverage), for a total volume of 300 mL (approximately 150 mL per aliquot).

DRUG

Placebo

Film-coated oral tablet

Trial Locations (1)

M5V 2T3

Syneos Health, Toronto

All Listed Sponsors
collaborator

Purdue Pharma LP

INDUSTRY

lead

Eisai Inc.

INDUSTRY

NCT03483636 - Study of Lemborexant-Alcohol Interaction in Healthy Subjects | Biotech Hunter | Biotech Hunter